SE452322B - Kristallina 1,1-dioxopenicillanoyloximetyl-6-(d-alfa-amino-alfa-fenylacetamido) penicillanat-p-toluensulfonat-hydrat och farmaceutiska kompositioner derav - Google Patents
Kristallina 1,1-dioxopenicillanoyloximetyl-6-(d-alfa-amino-alfa-fenylacetamido) penicillanat-p-toluensulfonat-hydrat och farmaceutiska kompositioner deravInfo
- Publication number
- SE452322B SE452322B SE8106404A SE8106404A SE452322B SE 452322 B SE452322 B SE 452322B SE 8106404 A SE8106404 A SE 8106404A SE 8106404 A SE8106404 A SE 8106404A SE 452322 B SE452322 B SE 452322B
- Authority
- SE
- Sweden
- Prior art keywords
- tosylate
- amino
- penicillanate
- phenylacetamido
- crystalline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8035156 | 1980-10-31 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE8106404L SE8106404L (sv) | 1982-05-01 |
| SE452322B true SE452322B (sv) | 1987-11-23 |
Family
ID=10517019
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8106404A SE452322B (sv) | 1980-10-31 | 1981-10-29 | Kristallina 1,1-dioxopenicillanoyloximetyl-6-(d-alfa-amino-alfa-fenylacetamido) penicillanat-p-toluensulfonat-hydrat och farmaceutiska kompositioner derav |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US4831025A (de) |
| JP (1) | JPS57126493A (de) |
| KR (1) | KR870001982B1 (de) |
| AT (1) | AT373893B (de) |
| AU (1) | AU543870B2 (de) |
| BE (1) | BE890938A (de) |
| CA (1) | CA1180696A (de) |
| CH (1) | CH647527A5 (de) |
| DE (1) | DE3143219A1 (de) |
| DK (1) | DK154219C (de) |
| ES (1) | ES8206531A1 (de) |
| FI (1) | FI813331L (de) |
| FR (1) | FR2493322B1 (de) |
| GB (1) | GB2114969B (de) |
| GR (1) | GR75369B (de) |
| IE (1) | IE51640B1 (de) |
| IL (1) | IL64009A (de) |
| IT (1) | IT1193735B (de) |
| LU (1) | LU83727A1 (de) |
| NL (1) | NL8104938A (de) |
| NO (1) | NO813683L (de) |
| NZ (1) | NZ198622A (de) |
| PH (1) | PH17820A (de) |
| PT (1) | PT73913B (de) |
| SE (1) | SE452322B (de) |
| ZA (1) | ZA817091B (de) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4432987A (en) * | 1982-04-23 | 1984-02-21 | Pfizer Inc. | Crystalline benzenesulfonate salts of sultamicillin |
| PH20068A (en) * | 1982-12-06 | 1986-09-18 | Pfizer | Process and intermediates for sultamicillin and analogs |
| KR910009271B1 (ko) * | 1989-06-20 | 1991-11-08 | 김영설 | 1,1-디옥소페닐실라노일 옥시메틸 D-6-[α-(메틸렌아미노)페닐-아세트아미도]-페니실라네이트와 그의 파라-톨루엔술폰산염 |
| ES2161602B1 (es) * | 1999-04-08 | 2003-02-16 | Asturpharma S A | Sintesis de 6-(d-alfa-(bencilidenaminofenilacetamido))penicilanato de 1,1-dioxopenicilanoiloximetilo y analogos. nuevos intermedios para la sintesis de sultamicilina. |
| US6991807B2 (en) * | 2000-02-24 | 2006-01-31 | Advancis Pharmaceutical, Corp. | Antibiotic composition |
| US6667057B2 (en) | 2000-02-24 | 2003-12-23 | Advancis Pharmaceutical Corp. | Levofloxacin antibiotic product, use and formulation thereof |
| US6663890B2 (en) | 2000-02-24 | 2003-12-16 | Advancis Pharmaceutical Corp. | Metronidazole antibiotic product, use and formulation thereof |
| US6638532B2 (en) | 2000-02-24 | 2003-10-28 | Advancis Pharmaceutical Corp. | Tetracycline—doxycycline antibiotic composition |
| AU2001239838A1 (en) * | 2000-02-24 | 2001-09-03 | Advancis Pharmaceutical Corporation | Therapeutic product, use and formulation thereof |
| CA2400818C (en) * | 2000-02-24 | 2009-01-06 | Advancis Pharmaceutical Corporation | Antibiotic and antifungal compositions |
| US6632453B2 (en) | 2000-02-24 | 2003-10-14 | Advancis Pharmaceutical Corp. | Ciprofoxacin-metronidazole antibiotic composition |
| US6544555B2 (en) | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
| US6730320B2 (en) | 2000-02-24 | 2004-05-04 | Advancis Pharmaceutical Corp. | Tetracycline antibiotic product, use and formulation thereof |
| US6663891B2 (en) | 2000-02-24 | 2003-12-16 | Advancis Pharmaceutical Corp. | Erythromyacin antibiotic product, use and formulation thereof |
| US7025989B2 (en) * | 2000-02-24 | 2006-04-11 | Advancis Pharmaceutical Corp. | Multiple-delayed released antibiotic product, use and formulation thereof |
| US6667042B2 (en) | 2000-02-24 | 2003-12-23 | Advancis Pharmaceutical Corp. | Fluroquinilone antibiotic product, use and formulation thereof |
| US6565882B2 (en) | 2000-02-24 | 2003-05-20 | Advancis Pharmaceutical Corp | Antibiotic composition with inhibitor |
| US6627222B2 (en) | 2000-02-24 | 2003-09-30 | Advancis Pharmaceutical Corp. | Amoxicillin-dicloxacillin antibiotic composition |
| US6669948B2 (en) | 2000-02-24 | 2003-12-30 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
| US6623758B2 (en) | 2000-02-24 | 2003-09-23 | Advancis Pharmaceutical Corp. | Cephalosporin-metronidazole antibiotic composition |
| US6610328B2 (en) | 2000-02-24 | 2003-08-26 | Advancis Pharmaceutical Corp. | Amoxicillin-clarithromycin antibiotic composition |
| US7157095B2 (en) * | 2000-10-13 | 2007-01-02 | Advancis Pharmaceutical Corporation | Multiple-delayed release antifungal product, use and formulation thereof |
| US7105174B2 (en) * | 2000-10-13 | 2006-09-12 | Advancis Pharmaceutical Corporation | Multiple-delayed release anti-neoplastic product, use and formulation thereof |
| US7074417B2 (en) * | 2000-10-13 | 2006-07-11 | Advancis Pharmaceutical Corporation | Multiple-delayed release anti-viral product, use and formulation thereof |
| US6541014B2 (en) * | 2000-10-13 | 2003-04-01 | Advancis Pharmaceutical Corp. | Antiviral product, use and formulation thereof |
| US20020197314A1 (en) | 2001-02-23 | 2002-12-26 | Rudnic Edward M. | Anti-fungal composition |
| US20040114368A1 (en) * | 2002-12-13 | 2004-06-17 | Shyu Shing Jy | Light device having rotatable or movable view |
| US20040265323A1 (en) * | 2003-05-16 | 2004-12-30 | Mccormick Beth A. | Compositions comprising pathogen elicited epithelial chemoattractant (eicosanoid hepoxilin A3), inhibitors thereof and methods of use thereof |
| WO2005009364A2 (en) | 2003-07-21 | 2005-02-03 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
| CA2533178C (en) | 2003-07-21 | 2014-03-11 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
| AU2004258953B2 (en) | 2003-07-21 | 2011-02-10 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
| WO2005016311A1 (en) | 2003-08-11 | 2005-02-24 | Advancis Pharmaceutical Corporation | Robust pellet |
| JP2007502294A (ja) | 2003-08-12 | 2007-02-08 | アドバンシス ファーマスーティカル コーポレイション | 抗生物質製剤、その使用法及び作成方法 |
| AU2004270170B2 (en) | 2003-08-29 | 2011-01-27 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
| AU2004273830B2 (en) | 2003-09-15 | 2011-03-24 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
| JP2008505124A (ja) | 2004-07-02 | 2008-02-21 | アドバンシス ファーマスーティカル コーポレイション | パルス送達用錠剤 |
| WO2007004239A1 (en) * | 2005-07-06 | 2007-01-11 | Morepen Laboratories Limited | New polymorphic form of sultamicillin tosylate and a process therefor |
| US8357394B2 (en) | 2005-12-08 | 2013-01-22 | Shionogi Inc. | Compositions and methods for improved efficacy of penicillin-type antibiotics |
| US8778924B2 (en) | 2006-12-04 | 2014-07-15 | Shionogi Inc. | Modified release amoxicillin products |
| US8299052B2 (en) * | 2006-05-05 | 2012-10-30 | Shionogi Inc. | Pharmaceutical compositions and methods for improved bacterial eradication |
| EP2874623B1 (de) | 2012-07-17 | 2018-12-12 | Bayer New Zealand Limited | Injizierbare antibiotische formulierungen und verfahren zu deren verwendung |
| EP2874624B8 (de) | 2012-07-17 | 2019-10-02 | Bayer New Zealand Limited | Injizierbare antibiotische formulierungen und verfahren zu deren verwendung |
| US11116737B1 (en) | 2020-04-10 | 2021-09-14 | University Of Georgia Research Foundation, Inc. | Methods of using probenecid for treatment of coronavirus infections |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1532222A (fr) * | 1963-10-28 | 1968-07-12 | Bristol Myers Co | Procédé de préparation de dérivés de la pénicilline |
| IE49880B1 (en) * | 1979-02-13 | 1986-01-08 | Leo Pharm Prod Ltd | Penicillin derivatives |
| BE881675A (fr) * | 1979-02-13 | 1980-08-12 | Leo Pharm Prod Ltd | B-lactames derives de l'acide penicillanique leur preparation et leurs utilisations therapeutiques |
| US4244951A (en) * | 1979-05-16 | 1981-01-13 | Pfizer Inc. | Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide |
| IE51516B1 (en) * | 1980-10-06 | 1987-01-07 | Leo Pharm Prod Ltd | 1,1-dioxapenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate napsylate |
-
1981
- 1981-10-06 IL IL64009A patent/IL64009A/xx not_active IP Right Cessation
- 1981-10-08 IE IE2361/81A patent/IE51640B1/en not_active IP Right Cessation
- 1981-10-13 NZ NZ198622A patent/NZ198622A/en unknown
- 1981-10-14 ZA ZA817091A patent/ZA817091B/xx unknown
- 1981-10-14 GB GB08131010A patent/GB2114969B/en not_active Expired
- 1981-10-15 AU AU76365/81A patent/AU543870B2/en not_active Expired
- 1981-10-19 PH PH26362A patent/PH17820A/en unknown
- 1981-10-20 AT AT0447781A patent/AT373893B/de not_active IP Right Cessation
- 1981-10-23 FI FI813331A patent/FI813331L/fi not_active Application Discontinuation
- 1981-10-23 IT IT68383/81A patent/IT1193735B/it active
- 1981-10-26 CA CA000388756A patent/CA1180696A/en not_active Expired
- 1981-10-27 DK DK472181A patent/DK154219C/da not_active IP Right Cessation
- 1981-10-29 GR GR66381A patent/GR75369B/el unknown
- 1981-10-29 SE SE8106404A patent/SE452322B/sv not_active IP Right Cessation
- 1981-10-30 DE DE19813143219 patent/DE3143219A1/de active Granted
- 1981-10-30 KR KR1019810004171A patent/KR870001982B1/ko active
- 1981-10-30 NL NL8104938A patent/NL8104938A/nl active Search and Examination
- 1981-10-30 CH CH6947/81A patent/CH647527A5/de not_active IP Right Cessation
- 1981-10-30 ES ES506751A patent/ES8206531A1/es not_active Expired
- 1981-10-30 FR FR8120476A patent/FR2493322B1/fr not_active Expired
- 1981-10-30 NO NO813683A patent/NO813683L/no unknown
- 1981-10-30 JP JP56175559A patent/JPS57126493A/ja active Granted
- 1981-10-30 PT PT73913A patent/PT73913B/pt unknown
- 1981-10-30 LU LU83727A patent/LU83727A1/fr unknown
- 1981-10-30 BE BE0/206403A patent/BE890938A/fr not_active IP Right Cessation
-
1987
- 1987-03-13 US US07/024,858 patent/US4831025A/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE452322B (sv) | Kristallina 1,1-dioxopenicillanoyloximetyl-6-(d-alfa-amino-alfa-fenylacetamido) penicillanat-p-toluensulfonat-hydrat och farmaceutiska kompositioner derav | |
| JPH0314811B2 (de) | ||
| CN1382682A (zh) | 2－(α－羟基戊基)苯甲酸盐及其制法和用途 | |
| WO2005085199A1 (en) | Novel polymorphs of etoricoxib | |
| JPS6020394B2 (ja) | 抗生物質の製造方法 | |
| SE452323B (sv) | Kristallint 1,1-dioxopenicillanoyloximetyl-6-(d-alfa-amino-alfa-fenylacetamido) penicillanat-2-naftensulfonat och farmaceutiska kompositioner derav | |
| JPH06504541A (ja) | ４−アミノ−３−アシルキノリン誘導体の塩およびその胃酸分泌抑制剤としての使用 | |
| KR870000291B1 (ko) | 결정상 벤조티아진 디옥사이드 염의 제조방법 | |
| RU2515557C9 (ru) | Фармацевтическая соль 8-метил-7-[5-метил-6-(метиламино)-3-пиридинил]-1-циклопропил-4-оксо-1,4-дигидро-3-хинолинкарбоновой кислоты, ее содержащая фармацевтическая композиция, лекарственное средство и способ лечения или профилактики бактериальных инфекций с помощью вышеуказанной соли | |
| CN1064681C (zh) | 杂环化合物 | |
| ZA200508640B (en) | Crystal of benzimidazole derivative and process for producing the same | |
| JPS6011040B2 (ja) | 抗菌剤類の製法 | |
| US4464379A (en) | Indol acetic acid derivatives and anti-inflamatory and related uses thereof | |
| GB2084572A (en) | 1,1-Dioxopenicillanoyloxymethyl 6-(D- alpha -amino- alpha -phenylacetamido)penicillanate napsylate | |
| JP3148235B2 (ja) | 抗菌性ペネム化合物 | |
| US3253990A (en) | N-methyl glucammonium salicylate and uses therefor | |
| JP3242975B2 (ja) | 消化管運動機能改善剤 | |
| JP2739328B2 (ja) | ベンズイミダゾール化合物の精製方法 | |
| JP3274855B2 (ja) | 抗菌性ペネム化合物 | |
| JPH09124653A (ja) | 水和物結晶及びその製造方法 | |
| HU203869B (en) | Process for producing salts ofnew acrylic acid derivatives and pharmaceutical compositions containing them | |
| NZ182323A (en) | Crystalline diastereomeric forms of 1-ethoxycarbonyloxyethyl-6-(hexahydro-1h-azepinyl)-methyleneamino-penicillanate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAL | Patent in force |
Ref document number: 8106404-0 Format of ref document f/p: F |
|
| NUG | Patent has lapsed |
Ref document number: 8106404-0 Format of ref document f/p: F |